Faeth Therapeutics, Inc. FTH
19.59 USD -0.06 (-0.31%)
Nov 4, 2026, 3:43 PM EST
19.08 Day range 20.44
7.45 52-week range 42.14
- YTD
- +83.60%
- 1 year
- +125.69%
Financial health
Altman Z-Score
20.78 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 5
- P/E 1
- P/B 2
Valuation
P/E -0.6×
FY 2018 5y median -0.6× FY 2025
P/S 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 0.7×
FY 2018 5y median 0.4× FY 2025
P/FCF -0.7×
FY 2018 5y median -0.7× FY 2025
EV/EBITDA -0.3×
FY 2018 5y median -0.4× FY 2025
EV/Sales 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -152.2%
FY 2018 5y median -152.2% FY 2025
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -113.4%
FY 2018 5y median -52.5% FY 2025
ROIC -110.9%
FY 2018 5y median -52.1% FY 2025
ROA -92.1%
FY 2018 5y median -45.9% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2018 FY 2025
Operating Income 29.6%
FY 2018 FY 2025
EPS (diluted) 30.4%
FY 2018 FY 2025
Free Cash Flow 17.5%
FY 2018 FY 2025
Financial Health
Current Ratio 5.1×
FY 2018 5y median 11.9× FY 2025
Quick Ratio 5.1×
FY 2018 5y median 11.9× FY 2025
Debt / Equity 0.1×
FY 2018 5y median 0.1× FY 2025
Net Debt / EBITDA 0.3×
FY 2018 5y median 0.2× FY 2025
Interest Coverage -697×
FY 2018 5y median -257× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31